Tesamorelin (Egrifta) for HIV-Associated Lipodystrophy

被引：0

|

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1363期

关键词：

EXCESS ABDOMINAL FAT;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：34 / 35

页数：2

相关论文

共 50 条

[1] Spotlight on Tesamorelin in HIV-Associated Lipodystrophy
Dhillon, Sohita
BIODRUGS, 2011, 25 (06) : 405 - 408
[2] Spotlight on Tesamorelin in HIV-Associated Lipodystrophy
Sohita Dhillon
BioDrugs, 2011, 25 : 405 - 408
[3] Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
Bedimo, Roger
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2011, 3 : 69 - 79
[4] Tesamorelin A Review of its Use in the Management of HIV-Associated Lipodystrophy
Dhillon, Sohita
DRUGS, 2011, 71 (08) : 1071 - 1091
[5] Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy
Spooner, Linda M.
Olin, Jacqueline L.
ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 240 - 247
[6] The HIV-associated lipodystrophy syndrome
Mauss, S
Schmutz, G
MEDIZINISCHE KLINIK, 2001, 96 (07) : 391 - 401
[7] HIV-ASSOCIATED LIPODYSTROPHY AND EXERCISE
Mutimura, E.
Stewart, A.
Crowther, N. J.
SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY, 2006, 62 (02) : 2 - 4
[8] HIV-associated lipodystrophy syndrome
Qaqish, RB
Fisher, E
Rublein, J
Wohl, DA
PHARMACOTHERAPY, 2000, 20 (01): : 13 - 22
[9] HIV-associated lipodystrophy syndrome
Milinkovic, Ana
COLLEGIUM ANTROPOLOGICUM, 2006, 30 : 59 - 62
[10] HIV-associated lipodystrophy syndrome
Mauss, S
AIDS, 2000, 14 : S197 - S207

← 1 2 3 4 5 →